Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

114P - Impact of elevated CEA level on the clinicopathological features of colorectal cancer patients

Date

07 Dec 2024

Session

Poster Display session

Presenters

Ahmed Almezaine

Citation

Annals of Oncology (2024) 35 (suppl_4): S1432-S1449. 10.1016/annonc/annonc1687

Authors

A.S.E. Almezaine1, A. Ellaithy2

Author affiliations

  • 1 Internal Medicine Dept., Tanta University, 31757 - TANTA/EG
  • 2 Internal Medicine Dept., Suez Canal University Hospital, 41522 - Ismailia/EG

Resources

This content is available to ESMO members and event participants.

Abstract 114P

Background

Carcinoembryonic antigen (CEA) is the most frequently used tumor marker in colorectal cancer (CRC) with a sensitivity of 80% and specificity of 70%. Some studies have discussed its significance in stage III; however, its association with other clinicopathological features is under investigated. The aim of this study was to cover this gap in the literature and evaluate the impact of CEA level on the clinicopathological features in different treatment modalities.

Methods

Data were extracted from SEER database for CRC patients )2000-2021(. Patients were first grouped according to the CEA level (positive or negative) with further stratification based on the treatment modality: curative (local excision or partial colectomy in stage I (and (partial or subtotal or total colectomy combined with systemic chemotherapy in stage II and III) or palliative chemotherapy in terminal stage IV. SPSS version 27 was used for data analysis.

Results

Out of 59,931 CRC patients, 51.4% were CEA positive. Negative CEA level had a significantly improved 5-year relative survival compared to the elevated CEA level (84.4% and 48.4%, P<0.000). In the group with a negative CEA level, females had quite similar 5-year relative survival but statistically significant compared to males (85.5% and 83.6%, P<0.001). The elevated CEA level had improved 5-year relative survival in females than males (51.1% and 46.1%, P<0.001). In the negative CEA group, Caucasians had a 5-year relative survival of 85% compared to African-Americans (79%, P<0.001), especially in stage III (85.3% and 80.4%, P<0.001) compared to the elevated CEA (48% and 44.2%, P < 0.001). Caucasians and African-Americans had similar 5-year relative survival in stage II (79.2% and 79.5%, P < 0.001). Married patients showed significantly higher 5-year survival in both negative CEA (86.3% and 81.2%, P<0.001) and elevated CEA level (50.5% and 46%, P<0.001).

Conclusions

Positive CEA status consistently correlates with poorer survival outcomes across all stages. Females and Caucasians have better survival rates. Incorporating psychological support, especially for married individuals, may enhance overall survival outcomes in addition to patients' quality of life, emphasizing the need for comprehensive patient care.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.